Navigation Links
Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research
Date:4/21/2009

Data Selected for Presentation Highlights Anti-Tumor effects of KRX-0401 (Perifosine)

NEW YORK, April 21 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced multiple presentations of preclinical data highlighting the anti-tumor effects of KRX-0401 (perifosine), the company's lead anti-cancer compound, at the American Association of Cancer Research (AACR) Annual Meeting, being held in Denver, Colorado.

Abstracts selected for presentation today, Tuesday, April 21, 2009, are as follows:

Abstract 3205:

Perifosine, as a single agent, inhibits neuroblastoma tumor cell growth in in vitro and in vivo preclinical models.

Author(s): Zhijie Li, Fei Tan, Jenna Tong, Amy McKee, Carol Thiele. National Cancer Inst., Bethesda, MD

Time/location: 8:00 AM - 12:00 PM, Hall B-F, Poster Section 10, # 13

Abstract Summary: In vitro studies in neuroblastoma cell lines indicate that perifosine treatment induced inhibition of Akt phosphorylation, and decreases of cell survival. In vivo studies of perifosine treatment led to significant increases in neuroblastoma tumor bearing mouse survival. In summary, Investigators conclude that the data indicates that as a single agent, perifosine targets activation of Akt in neuroblastoma cells and xenografts, and significantly inhibits tumor growth.

Abstract 4794:

Targeting breast cancer stem cells through inhibition of PI3-K/Akt/B-catenin signaling

Author(s): Korkaya Hasan, Amanda K. Paulson, Max S. Wicha. University of Michigan, Ann Arbor, MI

Time/location: 3:10 - 3:25 PM, Room 205-207, Colorado Convention Ctr.

Session Title: Cancer Stem Cell Approaches for Identification and Targeting

Abstract Summary: According to In
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
2. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
3. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
4. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
7. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
8. Keryx Biopharmaceuticals Announces Additions to Management Team
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
11. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 Carahsoft and CDS Federal Services ... 2014 at 2pm EST (11am PST), “Natural Language Processing: ... on how technology can turn raw, heterogeneous data into ... agencies. The online webinar will last approximately one hour. ...
(Date:1/14/2014)... a leading provider of strategic communications services to corporations and organizations ... the United States and Europe ... is returning to the firm,s Washington, D.C. ... than two years of service as Associate Commissioner for the Office ...
(Date:1/14/2014)... NY (PRWEB) January 14, 2014 EquitiesIQ, ... Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical ... serve the wound care market. , Free report download: ... restructured with a seasoned management team and Board, which ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo ... institutes from the National Institutes of Health (NIH) to ... more effective treatments to patients on a faster timeline. ... Translational Sciences (NCATS) and the National Eye Institute (NEI) ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3
... Biopharmaceutical manufacturers,responsible for an extensive repertoire ... and vaccines -- are faced with,many aspects ... product being assessed. A,new whitepaper from Microtest ... requirements associated with the aseptic processing of,a ...
... FRANCISCO, Aug. 12 VIA Pharmaceuticals,Inc. (Nasdaq: VIAP ... for the treatment of cardiovascular disease, announced today that,James ... of VIA,will present a company update at the Fourth ... Tuesday, August 19, 2008 at the Loews Lake,Las Vegas ...
... Aug. 12 DSM Biologics and MorphoSys,AG ... TecDAX) today,announced the signing of a Biopharmaceutical ... of MOR202. MOR202 is a,fully human HuCAL(R) ... the treatment of multiple myeloma. DSM Biologics ...
Cached Biology Technology:White Paper Explains Aspects of Testing From Purified Bulk Drug Substance to Sterile Liquid Final Drug Product 2VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference 2DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody 2DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody 3
(Date:4/23/2014)... School of Public Health-Bloomington has bolstered the link between ... strong association between heme iron, found only in meat, ... found that heme iron consumption increased the risk for ... was found between nonheme iron, which is in plant ... The study was published online ahead of print in ...
(Date:4/23/2014)... their mid-thirties and forties, face a devastating prognosis: ... decades. "Mutant" protein clusters, long blamed for the ... primary focus of therapies in development by pharmaceutical ... Gerardo Lederkremer and Dr. Julia Leitman of Tel ... in collaboration with Prof. Ulrich Hartl of the ...
(Date:4/23/2014)... University of Toronto Scarborough research shows that male black ... virgins a rare example of mate preference by ... UTSC post-doc Emily MacLeod and Maydianne Andrade, a professor ... controlled field studies and the wild that males overwhelmingly ... found male black widows can tell whether a potential ...
Breaking Biology News(10 mins):Study: Iron consumption can increase risk for heart disease 2On the defensive 2On the defensive 3Picky male black widow spiders prefer well-fed virgins 2
... colleagues have received a National Institutes of Health grant to ... messaging system affect cellular processes. ,Matthew Bennett, ... more than a million dollars over five years to gather ... goal is to create techniques to generate and analyze models ...
... German . Until recent decades the Atlantic ... to present-day Argentina. In the 1970s, after years of deforestation, ... cattle pastures. This study reveals an unexpected aspect of deforestation. ... show that the common practice of slash and burn left ...
... Science Exchange, in partnership with the open-access publisher PLOS ... of the Reproducibility Initiative a new ... their critical research findings. "In the ... a lot of public attention, particularly in the context ...
Cached Biology News:NIH backs Rice University study of delay in gene transcription networks 2Marine research in the Brazilian rainforest 2Marine research in the Brazilian rainforest 3Reproducibility Initiative to increase the value of biomedical research 2Reproducibility Initiative to increase the value of biomedical research 3
HiTrap NHS-activated HP, 1 x 5 ml. Category: Chromatography Systems & Accessories, Systems....
Human OSCAR MAb (Clone 259501)...
Human/Mouse G9a/EHMT2 MAb (Clone A8620A) Keywords: Eu-HMTase2...
Human M-CSF...
Biology Products: